Sie suchten nach: levodopi (Slowenisch - Englisch)

entakapon vedno predpisujemo kot dodatek k levodopi.
entacapone is always given as an adjunct to levodopa treatment.

zdravilo ongentys se daje kot dodatno zdravljenje k levodopi.
ongentys is to be administered as an adjunct to levodopa treatment.

učinkov zaviranja ali indukcije pri levodopi in karbidopi niso raziskovali.
inhibition or induction effects of levodopa and carbidopa have not been investigated.

zdravilo comtan pomaga levodopi pri lajšanju simptomov parkinsonove bolezni.
comtan aids levodopa in relieving the symptoms of parkinson's disease.

zdravilo entakapon teva pomaga levodopi pri lajšanju simptomov parkinsonove bolezni.
entacapone teva aids levodopa in relieving the symptoms of parkinson's disease.

družba je predstavila tudi podatke iz objavljene literature o levodopi in karbidopi.
the company also presented data from the published literature for levodopa and carbidopa.

ugotovljeno je, da dodajanje entakapona levodopi/karbidopi poveča biološko uporabnost levodope za 30 %.
the addition of entacapone to levodopa/carbidopa has been demonstrated to increase the levodopa bioavailability by 30%.

učinkovitost razagilina je bila ugotovljena v treh študijah: kot monoterapija v študiji i in kot dodatna terapija k levodopi v študijah ii in iii.
the efficacy of rasagiline was established in three studies: as monotherapy treatment in study i and as adjunct therapy to levodopa in the studies ii and iii.

redko so se ob levodopi/karbodopi pojavile konvulzije, vendar pa vzročna zveza z levodopo/karbidopo ni bila potrjena.
convulsions have occurred rarely with levodopa/carbidopa; however a causal relationship to levodopa/carbidopa therapy has not been established.

družba je v podporo uporabi zdravila stalevo uporabila nekatere podatke o zdravilu comtess/comtan in predstavila podatke iz objavljene literature o levodopi in karbidopi.
the company used some of the data from comtess/comtan to support the use of stalevo and presented data from the published literature for levodopa and carbidopa.

safinamid, ki je uporabljen kot dodatek k levodopi, lahko potencira neželene učinke levodope in poslabša predobstoječo diskinezijo, zaradi česar je potrebno zmanjšanje odmerka levodope.
safinamide used as an adjunct to levodopa may potentiate the side effects of levodopa, and pre- existing dyskinesia may be exacerbated, requiring a decrease of levodopa.

zdravilo razagilin mylan se lahko uporablja samostojno ali kot dodatek levodopi (drugemu zdravilu, ki se uporablja pri parkinsonovi bolezni) pri bolnikih z nihanji pri nadzoru njihovega stanja.
rasagiline mylan can be used either alone, or as an add-on to levodopa (another medicine used in parkinson’s disease) in patients who are having fluctuations in the control of their condition.

zdravilo azilect se lahko uporablja samostojno ali kot dodatek levodopi (drugemu zdravilu, ki se uporablja pri parkinsonovi bolezni) pri bolnikih z nihanji proti koncu obdobja med dvema odmerkoma levodope.
azilect can be used either alone, or as an add-on to levodopa (another medicine used in parkinson’s disease) in patients who are having ‘fluctuations’ towards the end of the period between levodopa doses.

družba je v podporo uporabi zdravila levodopa/carbidopa/entacapone orion uporabila nekatere podatke o zdravilu comtess/comtan in predstavila podatke iz objavljene literature o levodopi in karbidopi.
the company used some of the data from comtess/comtan to support the use of levodopa/carbidopa/entacapone orion and presented data from the published literature for levodopa and carbidopa.

o tem odlogu motoričnih zapletov pri pramipeksolu je treba presoditi glede na večje izboljšanje motorične funkcije pri levodopi (izmerjeno s srednjo spremembo pri klinični nevrološki preiskavi za bolnike s parkinsonovo boleznijo – po lestvici updrs).
this delay in motor complications with pramipexole should be balanced against a greater improvement in motor function with levodopa (as measured by the mean change in updrs-score).